{
    "nctId": "NCT02473861",
    "briefTitle": "EXercise Influence on Taxane Side Effects (EXIT) Study",
    "officialTitle": "EXercise Influence on Taxane Side Effects (EXIT) Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 31,
    "primaryOutcomeMeasure": "Change with treatment and maintenance post treatment in patient-reported taxane-related symptoms via the EORTC CIPN subscale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Born female\n* Age 19 or older\n* Histologically confirmed stage I-IIIA breast cancer diagnosis\n* Scheduled to receive neoadjuvant or adjuvant taxane-containing chemotherapy\n* Willing and able to attend baseline assessment prior to first taxane-containing treatment\n* Have reliable transportation to attend our exercise gym located near the Vancouver BCCA three times weekly for 8-13 weeks\n* Be able to read and communicate in English\n* Treating medical oncologist approval to participate\n\nExclusion Criteria:\n\n* Receipt of further chemotherapy treatments after taxane-containing treatments\n* Stage IV cancer\n* Acute or uncontrolled health conditions including heart disease, respiratory disease (COPD or severe asthma)\n* Diagnosis of diabetes at any time\n* Personal history of neurological disorder\n* Mobility issues that require a mobility aid or that prevent exercise on a bike, treadmill, or elliptical (includes orthopedic injury or arthritis that result in inability to exercise)\n* Body mass index \u226540 kg/m2\n* Previously received chemotherapy or thoracic radiation treatment",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}